Navigation Links
Ocu-pore Porous Orbital Implants

ProductsOcu-pore Porous Orbital Implants
Company Ceramisys
Item Ocu-pore Porous Orbital Implants
Features Fully biocompatible ceramic matrix which serves as a scaffold for rapid soft tissue ingrowth. Optimized for rapid and complete tissue infiltration. Full and permanent integration. Resists migration. High strength and can easily be drilled for a motility peg. Exhibits far better movement than traditional implants. Less lower lid sagging.
Description Ocu-pore Porous Orbital Implants are comprised only of synthetic, medical grade, hydroxyapatite and have a controlled microstructure designed to support soft tissue ingrowth. Ocu-pore is available in a range of convenient sizes. The material is manufactured using a proprietary synthetic process which allows us to produce a highly porous, fully interconnected, biocompatible ceramic matrix similar in nature to that found in human cancellous bone. The product provides a macro porous structure that serves as an ideal scaffold allowing rapid and complete soft tissue penetration throughout the entire implant. The device is permanent and will not resorb. Once integrated the device can easily be drilled to accept a motility peg if required.
Info Ceramisys
Customer Service: +44 (0)114 283 5981
Web site: http://www.ceramisys.com/

Related medicine products :

1. The APR Hip Family - Porous (collared)
2. The APR Hip Family - Porous (collarless)
3. The APR Hip Family - Porous HA
4. The Natural-Hip Family - High Demand Porous (collarless)
5. The Natural-Hip Family - High Demand Porous (collared)
6. The Natural-Hip Family - High Demand Porous (short neck)
7. The Natural-Hip Family - Specialty Porous Collared HA
8. The Natural-Hip Family - Specialty Porous collarless HA
9. The Foundation 470 Series Collarless Porous Stem
10. The Foundation 480 Series Collared Porous Stem
11. Karaya 5 Closed Pouch with Porous Cloth Tape
BioSign® Malaria - Rapid Malaria Antigen Test...
Paracheck Pf is a two site sandwich immunoassay for the detection of P. falciparum specific histidine rich protein 2 (Pf HRP-2) in whole blood samples....
DiaMed OptiMAL-IT is an immuno-chromatographic test, using monoclonal antibodies against the metabolic enzyme pLDH (parasite lactate dehydrogenase) of Plasmodium spp. These Mabs are classified in t...
Core Malaria Pv/Pf is a self performing, qualitative, sandwich immunoassay for the detection and differentiation of vivax malaria and falciparum malaria in whole blood samples....
Medicine Products:
(Date:4/28/2016)... ... 2016 , ... Point Source Audio® (PSA) , an ... today that the US Patent Office has approved its patent submission that covers ... design creates a lightweight and modular audio headset that has been said to ...
(Date:4/28/2016)... ... April 28, 2016 , ... Accreditation Commission ... Oncology Pharmacy Association (COPA) to develop a comprehensive Specialty Pharmacy Accreditation with Distinction ... an accreditation distinction. ACHC provides a wide range of pharmacy accreditation services that ...
(Date:4/28/2016)... ... April 28, 2016 , ... Starting today, ... the mail from USA Medical Prescription Assistance Program. They are customized to reflect ... mailed package will include a ready-to-use, state-themed card and, in the near future, ...
(Date:4/28/2016)... ... April 28, 2016 , ... For the 10,000 Americans ... smarter about an important part of overall well-being: mental health. Now, a new book—Staying ... promote healthy aging and “cognitive vitality,” which can include everything from honing your memory ...
(Date:4/28/2016)... ... April 28, 2016 , ... ... insurance co-operative bankruptcy to receive their prescription medications through America’s fastest-growing pharmacy ... prescription medications from over 180 American pharmaceutical companies for $35 per month, ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... April 28, 2016  ValGenesis, Inc., the ... Solutions (VLMS) today announced that a prominent ... sufferers of chronic kidney failure has selected ... their corporate validation process. The global medical ... solution to manage their validation processes electronically. ...
(Date:4/27/2016)... April 27, 2016  Hologic, Inc. (Nasdaq: ... results for the fiscal second quarter ended March ... of $0.24 increased 41.2%, and non-GAAP diluted EPS ... increased 5.8% on a reported basis, and 6.3% ... "We posted another good quarter, highlighted by 14.6% ...
(Date:4/27/2016)... PARIS , April 27, 2016 ... Year-Over-Year Including 42% Growth in Recurring Consumable Sales  ... Mauna Kea Technologies (Euronext: MKEA, OTCQX: MKEAY) ... today announced its sales for the first quarter ended ... business and the execution of its commercial strategy. ...
Breaking Medicine Technology: